We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCIR
RNS Number : 3027C
Circassia Pharmaceuticals Plc
12 April 2017
12 April 2017
Circassia Pharmaceuticals PLC
Notice of Preliminary Results
Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2016 on Tuesday 25 April 2017.
A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.
For further information please contact:
FTI Consulting Mo Noonan / Matt Moss +44 (0) 20 3727 1000
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORDMGMDNZDGNZG
(END) Dow Jones Newswires
April 12, 2017 04:00 ET (08:00 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
